S2B GmbH & Co. KG was founded in 2017 by Dipl. Ing. Rudolf Cordes with the intention of advancing innovative biotechnological solutions for agriculture and industry. With a small team of scientists, S2B develops new biotechnological processes for the production of plant-based active pharmaceutical ingredients (phytopharmaceuticals), antibiotic substitutes and cosmetic ingredients. The company focuses on strain development and fermentation. In addition to proven biotechnological high performers such as baker's yeast or Escherichia coli, we also exploit the potential of highly efficient fungi and microalgae. The company operates a well-equipped S1 laboratory at the Ahlhorn site and has bioreactor capacities from laboratory to pilot scale. S2B's business strategy is 100% based on research and development as well as licensing of our patent-protected processes.